Sign Up to like & get
recommendations!
0
Published in 2022 at "Anti-Cancer Drugs"
DOI: 10.1097/cad.0000000000001339
Abstract: Cisplatin (DDP) resistance limits therapeutic efficacy in patients diagnosed with ovarian cancer. Purvalanol A (Pur) is a novel cyclin-dependent kinase (CDK) inhibitor that has been demonstrated to induce apoptosis in various cancer cells. The present…
read more here.
Keywords:
ovarian cancer;
combination;
eoc cells;
resistance ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "Anti-Cancer Drugs"
DOI: 10.1097/cad.0000000000001423
Abstract: Epithelial ovarian cancer (EOC) is one of the most serious cancer. Circular RNA BNC2 (circBNC2) expression was decreased in EOC tissues. However, the molecular mechanism of circBNC2 remains unknown. The expression of circBNC2, microRNA-223-3p (miR-223-3p),…
read more here.
Keywords:
circbnc2;
mir 223;
223 larp4;
eoc cells ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2019 at "Biological Chemistry"
DOI: 10.1515/hsz-2019-0119
Abstract: Abstract Epithelial ovarian cancer (EOC) is the most common and deadly ovarian cancer. Most of the patients have abdominal/pelvic invasion and metastasis at the time of diagnosis, but the underlying mechanism remains unclear. Insufficiency of…
read more here.
Keywords:
ca9 signaling;
signaling pathway;
sohlh2 alleviates;
eoc cells ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "International Journal of Molecular Sciences"
DOI: 10.3390/ijms23084383
Abstract: Epithelial ovarian cancer (EOC) is the most lethal gynecologic malignancy and has a unique metastatic route using ascites, known as the transcoelomic root. However, studies on ascites and contained cellular components have not yet been…
read more here.
Keywords:
cellular components;
cancer cells;
ovarian cancer;
eoc cells ... See more keywords